|
|
|
AFRICA: MSF pressures Abbott on key ARV
[This report does not necessarily reflect the views of the United Nations]
JOHANNESBURG, 28 April (PLUSNEWS) - US drug giant Abbott Laboratories was on Thursday accused of withholding new heat-resistant tablet versions of its anti-AIDS drug Kaletra in developing countries.
International medical NGO, Medecins San Frontieres (MSF), said current refrigerated liquid versions of the drug being used in resource-limited settings, was creating treatments hurdles.
MSF president Rowan Gillies said in a statement: "... where refrigerators are a luxury, [Kaletra] is urgently needed by patients switching to second-line AIDS treatment. How can Abbott continue to drag its feet in filing for registration in most African countries?"
Kaletra is a key second-line treatment that is used after HIV-positive people naturally develop resistance to first-line combinations.
[ENDS]
:: MORE NEWS BRIEFS ::
|
|
|
|
|
|
|
|
| Links |
AIDS Media Center
|
The Global Fund to fight AIDS, Tuberculosis & Malaria
|
International Community of Women Living with HIV/AIDS
|
AEGIS
|
International HIV/AIDS Alliance
|
PlusNews does not take responsibility for info in links supplied.
|
|
|
|
|
|
[Back] [Home Page]
Click here to send any feedback,
comments or questions you have about PlusNews Website or if you prefer you can
send an Email to Webmaster
Copyright IRIN 2006
The material contained on www.PlusNews.org comes to you via IRIN, a UN humanitarian news and information service, but may not necessarily reflect
the views of the United Nations or its agencies.
All PlusNews material may be reposted or reprinted free-of-charge; refer to the IRIN copyright page for conditions of use. IRIN is a project of the UN
Office for the Coordination of Humanitarian Affairs.
|